The primary aim of this project is to gain a more complete picture of the social, and emotional challenges that patients with heart failure face. Racial and gender differences in responses to survey questions are of particular interest. Additionally, interviews will be used to gain more information about personal challenges in finding and paying for psychological treatment related to these social and emotional outcomes.

The objective of the RADIANCE CAP study is to continue to collect safety and effectiveness data on the Paradise System in hypertensive subjects.

This study is testing a medication called ziltivekmab to see if it can help people with heart failure.

This study is testing eplontersen as a treatment for Cardiac Amyloidosis.

The purpose of this study is to survey patients on their experiences being treated for Severe Aortic Stenosis

The purpose of this study is to define patient populations who may recover left atrial mechanical function rapidly (<24 hours) following cardioversion. Defining these characteristics will help us weigh the risks and benefits of anticoagulation following cardioversion.

This study is comparing two ways of treating Atrial Fibrillation (AF). Patients will either take continuous anticoagulation medications, or they will wear AF-sensing smartwatches and take anticoagulation medications for 30 days after an AF event.

We are seeking to improve knowledge around treatment of atrial fibrillation for primary care providers and patients through educational interventions.

Study the effects of a new drug LY3540378 in patients with heart failure

We are doing this study to look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with obesity and cardiovascular disease.